Table 3.

Established stability of continuous infusion beta-lactams [75,77,78,79,80,81].

Beta-Lactam Continuous Infusion	Stability
Piperacillin/tazobactam	16 g/day administered over 24 h
Cefepime	6 g/day administered over 24 h
Ceftazidime	6 g/day administered over 24 h
Ceftolozane/tazobactam	6 g/day administered over 24 h
Meropenem	1.5–3 g q12 h administered over 12 h (3–6 g/day)
Aztreonam	8 g/day administered over 24 h